Chordia Therapeutics, Dec-Feb (2Q) Ordinary Profit Loss Narrows

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Apr 11, 2025 11:30 am JST Earnings

190A Chordia Therapeutics Inc. 【J-GAAP】

Earnings Report

Chordia Therapeutics Inc. <190A> [TSE Growth] announced its financial results at noon (11:30) on April 11th. The ordinary loss (non-consolidated) for the cumulative second quarter of the fiscal year ending August 2025 (September 2024 to February 2025) expanded to a loss of 0.97 billion yen (compared to a loss of 0.8 billion yen in the same period last year).

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary loss for the March to August period (2H) is expected to expand to a loss of 1.4 billion yen (compared to a loss of 1.02 billion yen in the same period last year).

In the most recent three-month period, from December to February (2Q), the ordinary loss improved to a deficit of 0.36 billion yen (compared to a loss of 0.38 billion yen in the same period last year).

Kabutan News

Actual Results

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Sep - Feb, 2024	0	-996	-975	-976	-14.3	ー	Apr 11, 2025	J-GAAP
YoY	－	－	－	－	－

First Half Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Sep - Feb, 2024 Guidance	ー	ー	ー	ー	－	0	Oct 11, 2024	J-GAAP
Sep - Feb, 2024 Results	0	-996	-975	-976	-14.3	0	Apr 11, 2025	J-GAAP
Revision Rate	－	－	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar - Aug, 2024	0	-992	-1,023	-1,025	-17.5	0	Oct 11, 2024	J-GAAP
Mar - Aug, 2025 Guidance	ー	-1,438	-1,403	-1,404	-20.4	0	Apr 11, 2025	J-GAAP
YoY	－	-45.0%	-37.1%	-37.0%	-16.6%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Aug, 2024	0	-1,801	-1,824	-1,827	-31.1	0	Oct 11, 2024	J-GAAP
Aug, 2025 Guidance	ー	-2,434	-2,378	-2,380	-34.5	0	Oct 11, 2024	J-GAAP
YoY	－	-35.1%	-30.4%	-30.3%	-10.9%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Mar - May, 2024	0	-371	-374	-375	-6.7	-Inf	Jul 16, 2024	J-GAAP
Jun - Aug, 2024	0	-621	-649	-650	-11.1	-Inf	Oct 11, 2024	J-GAAP
Sep - Nov, 2024	0	-624	-615	-616	-9.1	-Inf	Jan 14, 2025	J-GAAP
Dec - Feb, 2024	0	-372	-360	-360	-5.3	-Inf	Apr 11, 2025	J-GAAP
YoY	－	－	－	－	－